Crinetics Pharmaceuticals Inc Asset Turnover Ratio (CRNX), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Crinetics Pharmaceuticals Inc   (NASDAQ: CRNX)
 

Crinetics Pharmaceuticals Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Crinetics Pharmaceuticals Inc asset turnover ratio, the ability of Crinetics Pharmaceuticals Inc 's assets to generate revenue in the second quarter 2026, increased sequentially to 0.03 in the second quarter (Jun 30 2026), a new company high.

Within sector 177 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2026 compared to the preceding quarter from 975 to 3808.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CRNX Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Asset Change 92.74 % 2.94 % -19.06 % 33.89 % 44.89 %
Y / Y Revenue Change 2336.28 % 2873.41 % - - 158.4 %
Asset Turnover Ratio (TTM) 0.03 0.01 0.01 0 0
CRNX's Total Ranking # 3808 # 975 # 3403 # 0 # 0
Seq. Asset Change 77.37 % 24.42 % -5.83 % -7.25 % -5.27 %
Seq. Revenue Change 134 % 74.22 % 4208.39 % -86.13 % 185.6 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 178
Healthcare Sector # 524
Overall Market # 3808

Asset Turnover Ratio Statistics
High Average Low
0.03 0.01 0
(Jun 30 2026)   (Jun 30 2018)




CRNX Company Profile • Back to CRNX Efficiency Comparisons • Compare CRNX Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Agape Atp Corporation  0.05 $ 1.152  Millions$ 24.729  Millions
Aclaris Therapeutics Inc   0.05 $ 8.219  Millions$ 178.602  Millions
Cytokinetics Incorporated  0.04 $ 67.670  Millions$ 1,514.781  Millions
Instil Bio Inc   0.04 $ 8.968  Millions$ 203.358  Millions
Camp4 Therapeutics Corporation  0.04 $ 4.216  Millions$ 100.772  Millions
Recursion Pharmaceuticals Inc   0.04 $ 54.855  Millions$ 1,356.462  Millions
Vistagen Therapeutics Inc   0.04 $ 2.501  Millions$ 62.393  Millions
Kyntra Bio Inc   0.04 $ 4.617  Millions$ 116.829  Millions
X4 Pharmaceuticals Inc  0.04 $ 9.441  Millions$ 244.340  Millions
Blue Water Vaccines Inc  0.03 $ 0.646  Millions$ 18.966  Millions
Crinetics Pharmaceuticals Inc   0.03 $ 42.156  Millions$ 1,261.374  Millions
Pluri Inc   0.03 $ 1.016  Millions$ 30.822  Millions
Tscan Therapeutics Inc   0.03 $ 7.111  Millions$ 216.114  Millions
Northwest Biotherapeutics Inc  0.03 $ 2.173  Millions$ 66.973  Millions
Tao Synergies Inc   0.03 $ 0.772  Millions$ 24.086  Millions
Atrium Therapeutics Inc   0.03 $ 35.974  Millions$ 1,166.283  Millions
Bioage Labs Inc   0.03 $ 10.355  Millions$ 348.641  Millions
Co diagnostics Inc   0.03 $ 0.721  Millions$ 26.893  Millions
Dbv Technologies S a   0.02 $ 5.018  Millions$ 223.351  Millions
Fate Therapeutics Inc   0.02 $ 6.491  Millions$ 301.907  Millions
Medicinova Inc   0.02 $ 0.920  Millions$ 44.080  Millions
Mangoceuticals Inc   0.02 $ 0.315  Millions$ 15.311  Millions
Bioxcel Therapeutics Inc   0.02 $ 0.742  Millions$ 38.133  Millions
Hyperion Defi inc   0.02 $ 1.401  Millions$ 79.440  Millions
Aspire Biopharma Holdings Inc   0.02 $ 0.103  Millions$ 6.093  Millions
Ataibeckley Inc   0.02 $ 4.473  Millions$ 265.553  Millions
Seres Therapeutics Inc   0.02 $ 1.883  Millions$ 125.218  Millions
Alumis inc   0.01 $ 7.398  Millions$ 533.040  Millions
Vyne Therapeutics Inc   0.01 $ 0.430  Millions$ 31.089  Millions
Anteris Technologies Global Corp   0.01 $ 2.242  Millions$ 166.751  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.